News & Awards

PixCell Medical Partners with Triolab to Distribute Hematological Analyzer HemoScreen™ in Sweden

How artificial intelligence can assist primary care physicians in cancer diagnosis

PixCell's point-of-care HemoScreen outperforms laboratory CBC analysis

PixCell Medical is proud to announce that we have been named an Innovative Company in PM360’s Innovations Issue 2020!

PixCell Medical's Point-Of-Care Hematology Analyzer Can Play a Key Role in Minimizing Disease Spread

PixCell Medical to Enhance NSW Health Pathology's Point-of-Care Testing Service

Changing Cancer Care By Bringing Diagnostics Home

PixCell Medical Announces Regulatory Approval from Australian Therapeutic Goods Administration

POC Diagnostics and "Super Bacteria"

PixCell Medical Bolsters its Leadership, Adding DR. David Stein as New Chairman of the Board

PixCell Plannig 2021 US Launch for HemoScreen Test, Readying Sepsis Test

Avishay Bransky, Ph.D., CEO and Co-founder of PixCell - Interview Series, by Antoine Tardif

FDA clears diagnostic device using flow and imaging cytometry

Point-of-care testing could offer a safer way to monitor cancer patients during a pandemic

The role of home-based blood diagnostics in future cancer care

Are we about to see a new dawn for point-of-care testing? , newsGP, Australia

Partnership with Pointof Care Diagnostics, Australia

How a Portable Israeli Blood Test Device Could Spur At-Home Chemo Treatments, NoCamels

Why Decentralized Diagnostics Are Needed for Pandemic Management, Healthcare Business Today

Bringing blood diagnostics home. Hillel's Tech Corner, The Jerusalem Post

Zealand University Hospital and PixCell Medical Cooperate to Advance Shift to Home Care to Cancer Patients, Clinical Lab Products

Happy Purim from PixCell Medical team

The HemoScreen successfully completes Clinical Evaluation with NSW Health Australia

The HemoScreen successfully completes Clinical Evaluation with the Karolinska Institute, Sweden

HemoScreen is being evaluated by Changing Cancer Care Consortium, Denmark-Germany as part of their goal to Improve, Shorten and Simplify Cancer treatment for the benefit of the patients

AACC's Disruptive Technology Award Competition PixCells's Hanan Ben-Asher to Present Next Generation Diagnosis and Early Detection

PixCell's Viscoelastic Focusing Technology Shifts the Paradigm in Hematology Point of Care Accessibility

Pixcell Presents at the AACC Annual Meeting Anaheim,CA

The HemoScreen successfully completes Clinical Evaluation at Linköping Healthcare Center, Östergötland County, Sweden

The HemoScreen successfully complete Clinical Evaluation with Uppsala University, Uppsala County, Sweden

Pixcell's team is working hard to prevent fire and clean the Carmel forest as part of Israel National "Good Deed Day"

The HemoScreen succesfully completes Clinical Evaluation with Gimo Primary Health Center, Uppsala County, Sweden

Happy Purim from PixCell Medical team

The HemoScreen successfully completes Clinical Evaluation with Unilabs, Sweden

The HemoScreen successfully completes Clinical Evaluation with North Zealand & Rigs Hospital, Denmark

PixCell presents as the AACC 70th Annual Meeting Chicago,IL

PixCell presents at the MIXiii-BIOMED, 17th National Life Science & Technology Week

PixCell is selected as one of 10 breakthrough health techs companies emerging from Israel

The HemoScreen successfully completes Clinical Evaluation with LabCorp, US

PixCell presents at the Clinical Chemistry and Pharmacology in Uppsala Region Spring meeting

PixCell presents at the Biotech Showcase, San-Francisco, US

PixCell presents at the LINUS Days Conference, Malmo, Sweden

PixCell presents at the UK NEQAS (H) 17th Annual Meeting - Education and Innovation in Blood Sciences Birmingham, UK

PixCell presents at the International Society for Laboratory Hematology (SLH) meeting, The Hague, The Netherlands